This content is from: Canada

Stretching the boundaries of patentability

The scope of IP protection in the biotechnology and life sciences sectors in Canada and the extent that such IP rights may preserve market exclusivity has been shaped by a number of recent authoritative judicial decisions. Arthur Renaud and Martin Kratz of Bennett Jones look at two areas that have particularly been shaped by the courts

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial